2021
DOI: 10.1177/10781552211015767
|View full text |Cite
|
Sign up to set email alerts
|

Global changes to the chemotherapy service during the covid-19 pandemic

Abstract: Purpose In response to the COVID-19 pandemic, changes to chemotherapy services were implemented as a means of managing imposed workload strains within health services and protecting patients from contracting COVID-19. Given the rapidly evolving nature of the pandemic many changes were rapidly adopted and were not substantiated by robust evidence. This study aimed to describe the changes adopted internationally to chemotherapy services, which may be used to guide future changes to treatment delivery. Methods A … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 17 publications
(25 reference statements)
0
5
0
Order By: Relevance
“…Furthermore, there was a lower proportion of patients receiving chemotherapy in 2020 when compared to 2019. This is indicative of the modification of SACT usage due to the COVID-19 pandemic as suggested in the survey by Chow et al [ 6 ]. Clinicians had to weigh up the risks of patients coming into hospital to receive chemotherapy and hence it was deemed more appropriate and safer for some patients to receive alternative treatment options with a less myelosuppressive profile.…”
Section: Discussionmentioning
confidence: 64%
See 1 more Smart Citation
“…Furthermore, there was a lower proportion of patients receiving chemotherapy in 2020 when compared to 2019. This is indicative of the modification of SACT usage due to the COVID-19 pandemic as suggested in the survey by Chow et al [ 6 ]. Clinicians had to weigh up the risks of patients coming into hospital to receive chemotherapy and hence it was deemed more appropriate and safer for some patients to receive alternative treatment options with a less myelosuppressive profile.…”
Section: Discussionmentioning
confidence: 64%
“…The COVID-19 pandemic has forced hospitals around the world to make difficult decisions regarding the continuation of care for cancer patients. In a recent survey completed by health care professionals working across 17 countries, all institutions implemented some sort of change into the delivery of anti-cancer treatment whether this be treatment delays, prioritisations or using less immunosuppressive drugs [ 6 ]. In our study, it was noted that there was an increase in the proportion of patients with stage IV disease being treated in 2020 when compared to 2019.…”
Section: Discussionmentioning
confidence: 99%
“…In a study exploring global changes to chemotherapy service during the pandemic, nearly half of institutions surveyed reported implementing treatment prioritisation strategies where treatment was postponed, reduced or stopped for some patients. 46 Evidence already shows that lower SES groups are less likely to receive treatment for colorectal cancer 47 and therefore this is another potential area where inequalities may be perpetuated.…”
Section: Discussionmentioning
confidence: 99%
“…Informed by prior rapid-cycle qualitative analysis approaches, we focused on specific research questions on implementation (ie, telemedicine barriers and facilitators) [ 20 ] and used the framework method to analyze free-text comments in Microsoft Excel [ 18 , 21 , 22 ]. Following an unstructured familiarization phase, initial codes were developed, and in a subsequent coding phase, final themes were identified, with relevant qualitative data tabulated by theme.…”
Section: Methodsmentioning
confidence: 99%